Search Main menu LEO Pharma Patients Therapeutic areas Products Research and Development Partnering Careers Section menu Management Organisation Mission & Vision Values Business Ethics Positions and views Global presence The LEO Foundation LEO Pharma Research Foundation History Media centre News News 2017 News 2016 News 2015 News 2014 News 2013 News 2012 News 2011 News 2010 News 2009 Downloads Social media Financial figures LEO Innovation Lab News Below you find a list of LEO Pharma's most recent press releases. The press releases are only intended for use by journalists. 27-09-2017 LEO Pharma’s innovation unit wins award for digital innovation 27-07-2017 LEO Pharma ranks second in global clinical trials transparency audit 23-06-2017 LEO Pharma appoints Chris Posner to lead US business 22-06-2017 Partnership Agreement for a Gel Formulation of betamethasone dipropionate in Japan: Treatment for Psoriasis Vulgaris 21-06-2017 LEO Pharma invests in Novopyxis to develop an aerosol-based drug delivery device for topical treatments 15-06-2017 LEO Pharma starts phase 3 clinical study for tralokinumab in atopic dermatitis 30-05-2017 Almirall and LEO Pharma join forces to advance dermatology research by setting a new standard for skin sampling 03-04-2017 LEO Pharma 2016 result surpassed expectations 06-03-2017 Klox Technologies and LEO Pharma set up company for BioPhotonic in dermatology 03-03-2017 LEO Pharma announces positive results from phase 2b clinical study for tralokinumab in atopic dermatitis. 02-11-2016 LEO Pharma and MorphoSys enter into strategic alliance 27-10-2016 LEO Pharma and healthy skin groups to launch NYSKIN 11-10-2016 LEO Pharma announces restructuring plans to streamline its organisation and support new portfolio 30-09-2016 LEO Pharma expands partnering presence with LEO Science & Tech Hub in Boston 30-09-2016 LEO Pharma announces collaboration with Washington University to enhance understanding of atopic dermatitis 13-09-2016 LEO Pharma strengthens global leadership to accelerate entry into biologics in dermatology 15-08-2016 LEO Pharma Research Foundation awards two promising and talented scientists in skin research 01-07-2016 LEO Pharma enters biologics through strategic partnership with AstraZeneca 24-06-2016 LEO Pharma strengthens Board of Directors 05-04-2016 Annual Results 2015: A satisfactory year with significant investments Contact media relations Head of Global External Communication Henrik Kyndlev hdtdk@leo-pharma.com TEL +45 3140 6180 Global Corporate Communication Maia Fredtoft Soechting mfddk@leo-pharma.com TEL +45 3119 3559 Footer menu News Global presence Contact Terms of use Clinical Trial Disclosure LEO Pharma A/S Industriparken 55 DK-2750 Ballerup Danmark CVR No. 56759514 Tel +45 4494 5888 Fax +45 7226 3321 Which site would you like to visit? We use cookies on this website The cookies help us gain a better understanding of how you use our website; display applications and functionalities, to optimise your website experience, to assign a unique identification number to you, and to help you remember your user ID and password when you return to the website. We also use cookies to generate statistical information. By continuing to browse our website, you are agreeing to our use of cookies If you want to know more about our cookie policy and how to avoid and delete cookies click here.